Wall Street Journal (subscription) |
Arizona Accuses Insys of Fraudulently Marketing Fentanyl Painkiller
Wall Street Journal (subscription) Insys Therapeutics Inc.'s legal woes worsened Thursday when the state of Arizona filed a lawsuit claiming the company improperly marketed a powerful opioid painkiller. Arizona's attorney general, Mark Brnovich, alleged in a suit filed early Thursday ... Arizona accuses Insys of fraudulent opioid marketing scheme |
Thursday, August 31, 2017
Arizona Accuses Insys of Fraudulently Marketing Fentanyl Painkiller - Wall Street Journal (subscription)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment